SPHK1 and neoplasm: For example, mass spectrometry followed by network analysis of tumor cells after chemotherapy treatment revealed that chemotherapy of tumor cells or administration of medicine can alter sphingolipid-related enzymes such as SMase, CERK, and SphK and subsequently alter cellular sphingolipids, which may help decipher the malignancy of tumors and drug resistance38,55–57.